Bioactive constituents
from natural sources are of great interest
as alternatives to synthetic compounds for the treatment of various
diseases, including diabetes mellitus. In the present study, phytochemicals
present in Leucaena leucocephala (Lam.)
De Wit leaves were identified by gas chromatography–mass spectrometry
and further examined by qualitative and quantitative methods. α-Amylase
enzyme activity assays were performed and revealed that L. leucocephala (Lam.) De Wit leaf extract inhibited
enzyme activity in a dose-dependent manner, with efficacy similar
to that of the standard α-amylase inhibitor acarbose. To determine
which phytochemicals were involved in α-amylase enzyme inhibition, in silico virtual screening of the absorption, distribution,
metabolism, excretion, and toxicity properties was performed and pharmacophore
dynamics were assessed. We identified hexadecenoic acid and oleic
acid ((Z)-octadec-9-enoic acid) as α-amylase inhibitors. The
binding stability of α-amylase to those two fatty acids was
confirmed in silico by molecular docking and a molecular
dynamics simulation performed for 100 ns. Together, our findings indicate
that L. leucocephala (Lam.) De Wit-derived
hexadecanoic acid and oleic acid are natural product-based antidiabetic
compounds that can potentially be used to manage diabetes mellitus.